On July 22, Qian Yi, head of the Pingshan Working Group of Southern Medical University and President of Pingshan Hospital, Pan Weibing, member of the Party Committee and vice president, Yan Tonghai, member of the Commission for Discipline Inspection and head of the Operation Management Department, Yang Yang, head of the Department of Science and Education visited Shenzhen Cell Valley. Our chairman Professor Shi Yuanyuan, deputy general manager Tang Xiaomeng, Chairman assistant Wei Zheng, R & D department head Zhao Lijun, General office director Luan Zhishi, senior R & D scientist Yang Yiqing and other warm reception.
 


President Qian Yi and his delegation first visited the Shenzhen Cell Valley Wisdom Exhibition Hall under the guidance of Wei Zheng, assistant to the chairman, and initially understood the technical principles and clinical application cases of gene modification and non-gene modification immune cell therapy technology; Subsequently, the actual situation of our GMP level production research and development laboratory and quality management system was deeply investigated, and the high standard and high quality construction of Shenzhen Cell Valley was highly uated.
 


 
 At the forum, Chairman Shi Yuan said that in the recent CAR-T clinical treatment, Shenzhen Cell Valley has carried out substantive and comprehensive cooperation with a number of hospitals, and has so far successfully prepared GMP-level targeting BCMA, CD19, CD19/CD22, CD7, CD38 and other CAR T cell products. Southern Medical University has significant advantages in medical research, teaching and clinical medicine, especially in international medicine and the integration of traditional Chinese and western medicine. It is hoped that through the sharing of resources on the two platforms and relying on the strong strength of disciplinary talents of Southern Medical University, a new pattern of collaborative high-quality development of medical education and research can be jointly built.


            

 President Qian Yi said that Southern Medical University Pingshan Hospital aims to build a regional medical highland in the east of Shenzhen, and strongly promotes the transformation of its affiliated hospitals from district-level hospitals to top-three hospitals directly under institutions of higher learning. Today is the era of rapid development of cell therapy. The purpose of this visit is to have in-depth exchanges with the Cell therapy product R&D team of Cell Valley, jointly discuss the latest technological trends and development trends in the medical field, seek cooperation areas and main directions in technology research and development and product innovation through resource sharing and complementary advantages, and jointly promote the integrated development of related fields.
Looking forward to the future, the two sides jointly hope that Southern Medical University Pingshan Hospital and Shenzhen Cell Valley can jointly create a comprehensive and refined new model of cooperation between medical enterprises, and jointly contribute to promoting the clinical application of cell therapy.